2019
Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians.
Qaseem A, Lin J, Mustafa R, Horwitch C, Wilt T, Forciea M, Fitterman N, Iorio A, Kansagara D, Maroto M, McLean R, Tufte J, Vijan S. Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians. Annals Of Internal Medicine 2019, 170: 547-560. PMID: 30959525, DOI: 10.7326/m18-2147.Peer-Reviewed Original ResearchConceptsAverage-risk womenBreast cancerGuidance statementsPatient populationGuidelines International Network libraryClinical breast examinationAge 50 yearsAGREE II instrumentNational Guideline ClearinghouseTarget patient populationBreast cancer screeningQuality of guidelinesAsymptomatic womenBiennial mammographyBreast examinationCancer screeningAmerican CollegeNational guidelinesMost womenClinical practiceCancerCliniciansAverage riskWomenLife expectancy
2018
Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians.
Qaseem A, Wilt T, Kansagara D, Horwitch C, Barry M, Forciea M, Fitterman N, Balzer K, Boyd C, Humphrey L, Iorio A, Lin J, Maroto M, McLean R, Mustafa R, Tufte J. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians. Annals Of Internal Medicine 2018, 168: 569-576. PMID: 29507945, DOI: 10.7326/m17-0939.Peer-Reviewed Original ResearchConceptsType 2 diabetesAmerican CollegePharmacologic therapyGlycemic controlGeneral healthScottish Intercollegiate Guidelines NetworkGuidelines International Network libraryClinical Systems ImprovementHemoglobin A1c targetPatient's general healthAmerican Diabetes AssociationAGREE II instrumentLife expectancyNational Guideline ClearinghouseCost of careA1C targetsNonpregnant adultsMost patientsPharmacologic treatmentClinical EndocrinologistsTreatment burdenDiabetes AssociationPatient preferencesChronic conditionsAdvanced age
2017
Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention.
Abara W, Qaseem A, Schillie S, McMahon B, Harris A, Abraham G, Centor R, DeLong D, Gantzer H, Horwitch C, Humphrey L, Jokela J, Li J, Lohr R, López A, McLean R. Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention. Annals Of Internal Medicine 2017, 167: 794-804. PMID: 29159414, DOI: 10.7326/m17-1106.Peer-Reviewed Original ResearchConceptsHepatitis B virusHepatitis B vaccinationEnd-stage renal diseaseB vaccinationRenal diseaseAmerican CollegeChronic hepatitis B virus infectionElevated alanine aminotransferase levelsHepatitis B virus infectionDisease controlAlanine aminotransferase levelsB virus infectionChronic liver diseaseHigh HBV prevalenceHBV endemic regionsHIV-positive personsHigh-risk personsHepatitis C virusBest practice statementsPublic safety workersCare Task ForceBest Practice AdviceHBV prevalenceUnvaccinated adultsHBV infectionTreatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians.
Qaseem A, Forciea M, McLean R, Denberg T, Barry M, Cooke M, Fitterman N, Harris R, Humphrey L, Kansagara D, McLean R, Mir T, Schünemann H. Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians. Annals Of Internal Medicine 2017, 166: 818-839. PMID: 28492856, DOI: 10.7326/m15-1361.Peer-Reviewed Original ResearchConceptsLow bone densityBone densityPharmacologic treatmentVertebral fracturesPatient populationAmerican CollegeSystematic reviewACP Clinical Guidelines CommitteeClinical Practice Guideline UpdateLong-term pharmacologic treatmentBone density monitoringClinical Guidelines CommitteeFracture risk profileWomen 65 yearsMenopausal estrogen therapyCost of medicationsLarge observational studiesTreatment of osteoporosisTarget patient populationProgestogen therapyEstrogen therapyAdverse eventsPharmacologic therapyOsteoporotic womenPhysician recommendation